Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1

Conditions

Obesity 3 Constipation 2 Vomiting 1 Radiation Induced Oral Mucositis 1 Pulmonary Disease, Chronic Obstructive 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Overweight 1 Obesity, Abdominal 1 Neoplasms 1 Nausea 1 Multiple Endocrine Neoplasia Type 1 1 Mucositis 1 Motor Activity 1 Lung Neoplasms 1 Heart Failure 1 Head and Neck Neoplasms 1 Dyspnea 1 Diabetes, Gestational 1 Chemotherapy-Induced Peripheral Neuropathy 1

Interventions

Radiotherapy 9 Cisplatin 8 Fibroblast Growth Factor 7 6 Low-Level Light Therapy 5 angiotensin I (1-7) 4 Radiation 4 Injections 4 Propolis 3 Morphine 3 Methotrexate 3 Leucovorin 3 Drug Therapy 3 Cryotherapy 3 glucarpidase 2 aluminum hydroxide, magnesium hydroxide, drug combination 2 Xylitol 2 Water 2 Radiotherapy, Intensity-Modulated 2 RRx-001 2 Probiotics 2 Pentoxifylline 2 Mouthwashes 2 Melphalan 2 Lidocaine 2 Ketamine 2 Interleukin 1 Receptor Antagonist Protein 2 Honey 2 Glutamine 2 Gabapentin 2 Fluorouracil 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mucositis × Standard of Care × Other × Clear all

NCT01917942 2017-07-12

RadioHum

Trans Tasman Radiation Oncology Group

Phase 3 Completed

Head & NeckOther

Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡